Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br Poult Sci ; 60(6): 675-682, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31321996

RESUMO

1. The real burden of Campylobacter spp. in Lebanon is still unknown. The aims of this study were to unravel the epidemiology of Campylobacter spp. in broilers at slaughterhouses in Tripoli, North of Lebanon and to characterise their antibiotic resistance profiles.2. From May to November 2015, sampling was performed through five repeated surveys from 15 slaughterhouses that sold chicken directly to Lebanese customers. Isolates were subjected to pulsed field gel electrophoresis (PFGE) and flaA-restriction fragment length polymorphism (flaA-RFLP).3. All investigated slaughterhouses were found to be positive for Campylobacter spp. Campylobacter coli was the predominant species (38 isolates) followed by C. jejuni (eight isolates). A noticeable level of resistance was detected among isolates against ciprofloxacin (97% of C. coli and 87.5% of C. jejuni), amoxicillin (89% of C. coli and 75% of C. jejuni), gentamicin (79% of C. coli and 50% of C. jejuni), and co-amoxiclav (24% of C. coli and 25% of C. jejuni). Erythromycin and ertapenem resistance were observed only in C. coli with the following percentages 74% and 13% respectively, but not in C. jejuni. PFGE and flaA-RFLP using DdeI as restriction enzyme divided the strains into 27 and 25 types respectively.4. The high observed genetic diversity of Campylobacter spp. revealed the complexity of the spread of this genus in broilers. This study highlighted the pressing need to monitor antibiotic resistance and to ensure food safety from 'farm to fork' in Lebanon.


Assuntos
Infecções por Campylobacter/veterinária , Campylobacter/efeitos dos fármacos , Galinhas/microbiologia , Doenças das Aves Domésticas/epidemiologia , Matadouros , Animais , Antibacterianos/farmacologia , Campylobacter/classificação , Campylobacter/genética , Infecções por Campylobacter/epidemiologia , Infecções por Campylobacter/microbiologia , Ceco/microbiologia , Farmacorresistência Bacteriana , Eletroforese em Gel de Campo Pulsado/veterinária , Flagelina/genética , Doenças Transmitidas por Alimentos/epidemiologia , Doenças Transmitidas por Alimentos/microbiologia , Variação Genética , Humanos , Líbano/epidemiologia , Reação em Cadeia da Polimerase/veterinária , Polimorfismo de Fragmento de Restrição , Doenças das Aves Domésticas/microbiologia , Prevalência , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/veterinária
2.
Probiotics Antimicrob Proteins ; 6(3-4): 177-85, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24880436

RESUMO

Emerging resistance to antiviral agents is a growing public health concern worldwide as it was reported for respiratory, sexually transmitted and enteric viruses. Therefore, there is a growing demand for new, unconventional antiviral agents which may serve as an alternative to the currently used drugs. Meanwhile, published literature continues shedding the light on the potency of lactic acid bacteria (LAB) and their bacteriocins as antiviral agents. Health-promoting LAB probiotics may exert their antiviral activity by (1) direct probiotic-virus interaction; (2) production of antiviral inhibitory metabolites; and/or (3) via stimulation of the immune system. The aim of this review was to highlight the antiviral activity of LAB and substances they produce with antiviral activity.


Assuntos
Antivirais/administração & dosagem , Bacteriocinas/imunologia , Lactobacillaceae/imunologia , Probióticos/administração & dosagem , Viroses/tratamento farmacológico , Animais , Humanos , Lactobacillaceae/genética , Viroses/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...